Simple breath analysis could be used for colorectal cancer screening

NewsGuard 100/100 Score

A new study published in BJS has demonstrated for the first time that a simple breath analysis could be used for colorectal cancer screening. The study is part of the "Improving Outcomes in Gastrointestinal Cancer" supplement.

Cancer tissue has different metabolism compared to normal healthy cells and produces some substances which can be detected in the breath of these patients. Analysis of the volatile organic compounds (VOCs) linked to cancer is a new frontier in cancer screening.

Led by Donato F. Altomare, MD, of the Department of Emergency and Organ Transplantation at the University Aldo Moro of Bari, researchers collected exhaled breath from 37 patients with colorectal cancer and 41 healthy controls which was processed offline to evaluate the VOC profile. VOCs of interest had been identified and selected, and VOC patterns able to discriminate patients from controls set up.

A probabilistic neural network (PNN) was used to identify the pattern of VOCs that better discriminated between the two groups.

Results showed that patients with colorectal cancer have a different selective VOC pattern compared with healthy controls, based on analysis of 15 of 58 specific compounds in exhaled breath samples.

The PNN in this study was able to discriminate patients with colorectal cancer with an accuracy of over 75%, with the model correctly assigning 19 patients.

"The technique of breath sampling is very easy and non-invasive, although the method is still in the early phase of development," Altomare notes. "Our study's findings provide further support for the value of breath testing as a screening tool."

Source: Wiley

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels